IMARC Research has moved to a new office in the Minneapolis area, in Minnetonka. The office will continue to be managed by Jim Moat, Director of Clinical Monitoring Services.
Jim is a Certified Clinical Research Associate with over 26 years of experience in medical device product development, having managed all phases of clinical studies – from pre-market strategy to post-market surveillance.
“Minneapolis is a strong medical device market, so this new location will allow us to better serve our current clients and develop exciting new partnerships,” IMARC CEO and President Sandra Maddock said. “We are eager to assist in advancing clinical research using our various service offerings to ensure compliance throughout the entire clinical trial lifecycle."
IMARC opened its first Minneapolis office in the area in 2016. Having a second location continues IMARC’s office-based model, while providing increased flexibility for travel throughout the US and Canada.
The move to a new office not only allows room for more staff, it will give the team space to host meetings with clients and potential clients.
If you are interested in learning more information about the expansion or services, please give us a call.